The development of RNA-targeted therapies (ASOs) created to target and correct aberration in splicing and restore typical RNA processing would provide rationale for a new treatment consideration towards ALS associated with TARDBP [180]. Here, TARDBP is linked to amyotrophic lateral sclerosis.